Target intelligence / Profile preview

NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 6, pseudogene

Molecular classification: Other (Pseudogene)

Overview

A pseudogene corresponding to the NADH dehydrogenase (ubiquinone) 1 beta subcomplex subunit 6 gene. Pseudogenes are genomic DNA sequences similar to normal genes but are non-functional; they typically arise from gene duplication or retrotransposition and do not code for functional proteins. As such, ENSG00000271014 is not a therapeutic target, does not play a direct biological role, and has no established links to disease, drug interactions, or biomarker status.

Other names: NDUFB6 pseudogeneNDUFB6PNADH dehydrogenase (ubiquinone) 1 beta subcomplex, 6, 17kDa pseudogene

Beyond the preview

Go deeper on NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 6, pseudogene.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 6, pseudogene.

Explore the full profile